Price T Rowe Associates Inc. MD Lowers Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Price T Rowe Associates Inc. MD reduced its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 2.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 279,487 shares of the biotechnology company's stock after selling 7,456 shares during the period. Price T Rowe Associates Inc. MD owned 0.37% of Axon Enterprise worth $166,106,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of AXON. Harvest Investment Services LLC bought a new stake in shares of Axon Enterprise during the 4th quarter valued at $1,697,000. Soros Capital Management LLC grew its holdings in Axon Enterprise by 510.3% in the fourth quarter. Soros Capital Management LLC now owns 9,619 shares of the biotechnology company's stock worth $5,717,000 after purchasing an additional 8,043 shares during the period. OneDigital Investment Advisors LLC lifted its holdings in shares of Axon Enterprise by 22.3% during the fourth quarter. OneDigital Investment Advisors LLC now owns 2,510 shares of the biotechnology company's stock valued at $1,492,000 after purchasing an additional 457 shares during the last quarter. Tower Research Capital LLC TRC increased its position in Axon Enterprise by 70.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,396 shares of the biotechnology company's stock valued at $3,207,000 after buying an additional 2,226 shares in the last quarter. Finally, Thematics Asset Management bought a new stake in Axon Enterprise in the fourth quarter worth $9,648,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently issued reports on AXON. The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. Needham & Company LLC reaffirmed a "buy" rating and issued a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, April 23rd. Barclays reiterated a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Finally, TD Cowen began coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and a consensus target price of $626.45.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded up $11.29 during midday trading on Friday, hitting $632.39. 179,384 shares of the company's stock traded hands, compared to its average volume of 754,387. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market capitalization of $49.23 billion, a price-to-earnings ratio of 163.41, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. The firm has a fifty day moving average of $551.54 and a 200 day moving average of $575.64. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. The trade was a 0.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 6.10% of the company's stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.